[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vitamin D reduces autoimmune disease", "description": "Come on government, change the out dated guidelines. John's text books, free downloads,\n\nhttp://159.69.48.3/\n\nVitamin D regulates a wide array of genes involved in inflammation and immunity,\n \ninconsistently associated with reduced risk of several autoimmune diseases in observational studies\n\nActive form of vitamin D regulates genes, inflammation, acquired and innate immune responses\n\nDietary marine derived long chain omega 3 fatty acids decrease systemic inflammation in some autoimmune diseases\n\nEvidence is needed on whether omega 3 fatty acids lower the risk of developing autoimmune disease \n\nVitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial\n\nhttps://www.bmj.com/content/376/bmj-2021-066452\n\nTo investigate whether vitamin D and marine derived long chain omega 3 fatty acids reduce autoimmune disease risk. \n\nVitamin D and omega 3 trial (VITAL), a nationwide (US), randomized, double blind, placebo controlled trial\n\nN = 25, 871\n\nconsisting of,\n\n12, 786 men \u226550\n\n13, 085 women \u226555\n\n18,046 non- Hispanic white\n\n5,106 black\n\n2,152 as other racial and ethnic groups\n\nMean age was 67.1\n\nINTERVENTIONS\n \nVitamin D (2000 IU/day) or placebo\n\nOmega 3 fatty acids (1000 mg/day) or placebo\n\nParticipants self-reported all incident autoimmune diseases from baseline to a median of 5.3 years,\n\nthese diseases were confirmed by medical record review\n\n\n\n\n\n\n\nIn the vitamin D arm\n\nTreatment group\n\n123 developed an autoimmune disease\n\nPlacebo group\n\n155 developed an autoimmune disease\n\nHazard ratio 0.78\n\nP = 0.05\n\nIn the omega 3 fatty acids arm\n\nTreatment group\n\n130 developed an autoimmune disease\n\nPlacebo group\n\n148 developed an autoimmune disease\n\nP=0.19\n\nCONCLUSIONS\n \nVitamin D supplementation for five years\n\nwith or without omega 3 fatty acids, \n\nreduced autoimmune disease by 22%\n\nOmega 3 fatty acid supplementation\n\nwith or without vitamin D,\n\nreduced the autoimmune disease rate by 15%\n\n(not statistically significant)\n\nThe clinical importance of this trial is high because these are well tolerated, non-toxic supplements,\n \nand other effective treatments to reduce the incidence of autoimmune diseases are lacking \n\nAutoimmune diseases\n\nRheumatoid arthritis\n\nPolymyalgia rheumatica\n\nHashimoto\u2019s thyroiditis, too little thyroid hormone)\n\nPsoriasis\n\nType 1 diabetes mellitus\n\nMultiple sclerosis\n\nLupus\n\nInflammatory bowel disease (Crohn\u2019s Ulcerative colitis)\n\nAddison\u2019s (too little of cortisol)\n\nGrave\u2019s (too much thyroid hormone),  \n\nMyasthenia gravis\n\nPernicious anemia\n\nAutoimmune vasculitis\n\nCeliac disease (gluten protein from grains)\n\nInflammatory autoimmune response to self-tissues\n\nThird leading cause of morbidity in the industrialized world\n\nChronic conditions\n\nIncreasing prevalence with age\n\nLack of effective treatments\n\nMore about the VITAL RCT\n\nhttps://clinicaltrials.gov/ct2/show/NCT01169259\n\nVITamin D and OmegA-3 TriaL (VITAL) \n\nA randomized clinical trial, US based\n\nN =  25,871\n\nInvestigating\n\nDaily dietary supplements of vitamin D3 (2000 IU),\n\nor omega-3 fatty acids (Omacor\u00ae fish oil, 1 gram),\n\nreduces the risk of developing,\n\ncancer\n\nheart disease\n\nstroke,\n\nin people with no specific history\n\n 5-year intervention phase (study pill-taking, median 5.3 years) has ended\n\npost-intervention observational follow-up, ongoing", "link": "https://www.youtube.com/watch?v=Y4ASN8VXuL8", "date_published": "2022-05-29 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]